The largest database of trusted experimental protocols

11 protocols using nexera uplc

1

UPLC-MS based Metabolic Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metabolic profiling was analyzed using a Nexera UPLC (Shimadzu, Kyoto, Japan) system fitted with Q-Exactive quadrupole-Orbitrap mass spectrometer equipped with heated electrospray ionization (HESI) source (Thermo Fisher Scientific, Waltham, MA, USA). For sample preparation, acetonitrile:water (6:4) was used as Solvent A, while acetonitrile:isopropanol (1:9) as Solvent B. Both solvents contained 0.1% formic acid and10 mmol/L ammonium formate. Samples were run on an ACQUITY UPLC BEH C18 column in both positive and negative modes. With the mass range of the instrument set at m/z 120–1800, the precursor and product ions with accurate m/z on the mass spectrometry profile were matched against LipidBlast database.
+ Open protocol
+ Expand
2

Quantification of Antidiabetic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum concentrations of glibenclamide, glimepiride and rosiglitazone were analyzed by liquid chromatography – tandem mass spectrometry. All samples were fortified with 10 ng/mL tolbutamide (Sigma–Aldrich) as internal standard. Respective volumes of mouse serum were precipitated with the threefold volume of acetonitrile (−20 °C) and centrifuged for 10 min at 14,000 g. The supernatant was dried under vacuum conditions at 60 °C and subsequently reconstituted with 0.2% formic acid. For all measurements a QTRAP 6500 triple quadrupole MS (Sciex) coupled to a Nexera UPLC (Shimadzu) was used under positive electrospray ionization (ESI) conditions. The system was equipped with an Accucore C8 (50 × 3 mm, 2.6 μm particle size, Thermo Fisher). Gradient elution was applied over 14 min by using (A) 0.2% formic acid, pH 2.5 and (B) acetonitrile with Tmin/B [%] 0.2/2, 8.0/60, 10.0/100, 12.0/100, 12.1/2, and 14.0/2. For quantification (+) MRM ion transitions were m/z 494.1 to 169.0, 491.2 to 126.1, 358.1 to 135.1 for glibenclamide, glimepiride and rosiglitazone, respectively. Collision energies (CE) were set to 35 [eV]. tolbutamide was determined with m/z 271.1 to 155.1 and a CE with 27 [eV].
+ Open protocol
+ Expand
3

LC-MS Analysis of Compound Solubility

Check if the same lab product or an alternative is used in the 5 most similar protocols
The compounds were solubilized in DMSO
to generate a 10 mM solution. Pure and mixed samples (TCO ligand/Tz
thalidomide 1:1) were then analyzed by LC-MS on a Shimadzu Nexera
UPLC coupled with a Shimadzu LCMS-2020 single-quadrupole MS using
a YMC-Triart C18 column (50 × 2.0 mm, 1.9 μm) at 45 °C.
Gradient elution was performed from 3% acetonitrile to 99% acetonitrile
in 10 mM ammonium bicarbonate pH 9.4 over 0.7 min.
+ Open protocol
+ Expand
4

Quantitative Metabolomic Analysis of FbP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Levels of FbP for NCM3722 grown in succinate, sorbitol or acetate as a sole carbon source were analyzed by a targeted mass spectrometry‐based quantitative metabolomic approach in biological duplicate with four samples per group of assay. Briefly, for each sample, cell pellets (3–4×109) were resuspended in 3:1 MeOH:H2O (v/v), subjected to sonication with 500 W for 10 min, and next centrifuged for 10 min at 4 °C. The supernatant was collected and dried in a lyophilizer. The powder was resuspended in 2:8 MeOH:H2O (v/v) and centrifuged for 10 min at 4°C, and then, the supernatant was ready for detection. FbP analysis was performed using 10 μl of sample loaded into a Nexera UPLC (SHIMADZU) with an ACQUITY UPLC C18 column (100 × 2.1 mm, 1.7 μm, Waters) and underwent gradient elution procedures; then the sample was ionized by ESI and detected by QE high‐resolution mass spectrometer (Thermo) with Xcalibur 4.0 workstation in the negative ion mode, scanning precursor ion m/z 338.99 for FbP. The amount of FbP in unknown samples was calculated by peak areas when compared with that of an FbP standard.
+ Open protocol
+ Expand
5

Soluble Sugar Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Soluble sugar (fructose, glucose, sucrose, and sorbitol) contents were evaluated using the UFLC method with evaporative scattering detection (ELSD) [43 (link)]. About 1 g of fresh plant tissue was ground and diluted with deionized water. The extraction was carried out for 4 h at room temperature, centrifuged at 14,000× g rpm for 15 min. A cleanup step was performed before the chromatographic analysis: 1 mL of the supernatant was mixed with 1 mL 0.01% (w:v) ammonium acetate in acetonitrile and incubated for 30 min at 4° C. After incubation, samples were centrifuged at 14,000× g rpm for 15 min and filtered through 0.22 µm PTFE syringe filter (VWR International, Radnor, PA, USA). Analysis was performed on a Shimadzu Nexera UPLC (Kyoto, Japan) system. Separation was performed on a Supelcosil 250 × 4 mm NH2 column (Supelco, Bellefonte, PA, USA) using 77% acetonitrile as the mobile phase at 1 mL min−1 flow rate. The calibration method (R2 < 0.99) was used for each individual sugar quantification (mg g−1 in FW).
+ Open protocol
+ Expand
6

Lipidomic Analysis of PA64S Florets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sixty milligrams of florets of PA64S (F) and PA64S (S) at stage 7 were used to dissolve the extracted lipids. A Nexera UPLC (Shimadzu, Kyoto, Japan) system fitted with a Q-Exactive quadrupole-orbitrap mass spectrometer equipped with a heated electrospray ionization (HESI) source (Thermo Fisher Scientific, Waltham, MA, USA) was used to analyze the lipidomic analyses. The acquired LCsingle bondMS raw data were analyzed by the progenesis QI software (version 2.3, Waters Corporation, Milford, MA, USA). The positive and negative data were combined to obtain combined data that were imported into the SIMCA software package (version 14.1, Umetrics, Umeå, Sweden). The VIP value of the first principal component of the OPLS-DA model was greater than 1, and the p-value of the t test was less than 0.05 as the criteria for screening differential lipids. Each sample was represented by five biological replicates.
+ Open protocol
+ Expand
7

Quantification of Intracellular Nucleotides

Check if the same lab product or an alternative is used in the 5 most similar protocols
Shock-frozen pellets from 1–2 × 106 iPSC-derived myeloid cells were reconstituted in 500 µl water and sonicated on ice for 10 s. Lysate volumes of equal total cell numbers were precipitated by adding 250-µl volume of acetonitrile and centrifuged at 16,200 rpm for 2 min. Supernatant was transferred to a new vial, dried under nitrogen flow, and resuspended in 50 µl water. A calibration curve, containing a mixture of ATP, ADP, and AMP, ranging from 0 to 10 µmol/liter (0, 0.01, 0.1, 1, and 10 µmol/liter) was used to quantify nucleotides. Nucleotide quantification was performed using a Triple-Quad Mass Spectrometer (8040; Shimadzu) equipped with a turbo ion spray source and coupled to a Nexera UPLC (Shimadzu).
+ Open protocol
+ Expand
8

Antibody Glycosylation Analysis by UPLC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cultivation samples were centrifuged at 1000g for 10 min (Rotanta 460 R, Hettich Zentrifugen, Germany), and the supernatant was purified using Protein A affinity chromatography. Enzymatic digestions were performed using trypsin, according to the protocol described before (Ozohanics et al. 2012 (link); Turiák et al. 2011 (link)). UPLC-MS analysis of the antibody digest was performed on a Nexera UPLC (Shimadzu Corporation) coupled to a high-resolution micrOTOF-Q II mass spectrometer (Bruker Corporation). Chromatographic conditions were the following: reversed-phase column (Aeris Peptide 1.7-μm XB-C18 particles, Phenomenex Inc., USA) and gradient elution (solvent A 0.1 v/v% formic acid in water; solvent B 0.1 v/v% formic acid in 10 % water and 90 % acetonitrile mixture; flow rate 225 μL/min flow rate, column temperature 30 °C). Mass spectrometric conditions were the following: positive electrospray ionization mode (capillary voltage 4.5 kV; dry gas flow rate 12.0 L/min; dry temperature 200 °C; end plate offset 500 V) and scans acquired in the 140–2000 m/z range. The relative abundance of high-mannose glycoforms in the product amount expressed between two sampling events (i.e., two glycoform measurements) was calculated by using the mass balance in Eq. 1 in order to identify links between specific productivity and product quality. ΔrelativeM5=M5nPnM5n1Pn1PnPn1
+ Open protocol
+ Expand
9

Lipid Metabolomics Analysis of Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three representative mice in each group were selected to perform lipid metabolomics analysis using ultra-performance liquid chromatography-mass spectrometry (LC/MS) by Shanghai LuMing Biological Technology Co. Ltd. (Shanghai, China). Briefly, samples were separated using a Nexera UPLC (Shimadzu, Kyoto, Japan) and analyzed by mass spectrometry with Q Exactive (Thermo Scientific). Heated electrospray ionization (HESI) was used for detection in the positive and negative ion modes, respectively. Differentially expressed lipid metabolisms were identified using the DESeq R package functions estimateSizeFactors and nbinomTest. A p value of <0.05 and fold change of >2 or fold change of <0.5 were set as the threshold values for significantly differential expression. The KEGG pathway enrichment analysis of the differential expressed lipid metabolisms were respectively performed using R based on the hypergeometric distribution.
+ Open protocol
+ Expand
10

Citrullinated LL-37 Peptide Stability

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the stability of citrullinated forms of LL-37 in different environments, the peptides were added to NETs, inflamed (from RA patients) and control (from healthy individuals) human sera, as well as to synovial fluid obtained from rheumatoid arthritis patients. Briefly, all biological samples were centrifuged at 13,000 rpm for 15 min to remove lipids and precipitated material. Supernatants (900 μl) were mixed with 100 μl peptide solutions (1 mg/ml solution in PBS). Peptides mixed with PBS were used as a control. Samples were incubated at 37 °C and at different time points aliquots (50 μl) were withdrawn and treated with 50 μl of 6 M urea and 50 μl 6% TFA to denature all proteins in a sample. Next, samples were centrifuged at 13,000 rpm, 15 min and peptides in supernatants were separated by UPLC Nexera (Shimadzu Japan) on the C8 analytical column (Aeris) equilibrated with 0.1 TFA in water at flow rate 0.4 ml/min. Peptides were eluted with acetonitrile gradient up to 55% developed in 12 min. Proteinaceous material eluted from the column was detected at 208 nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!